Medical experts in Sheffield have hailed as a "game changer" trials of a drug that could reduce the recurrence of bladder ...

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced significant progress in its ongoing ...

According to Bladder Cancer UK, the main symptoms of bladder cancer are: ...

Immunotherapy is a modern approach to cancer treatment that uses a patient's own immune system to help fight tumors.

A new artificial intelligence-powered tool called MISO (Multi-modal Spatial Omics) can detect cell-level characteristics of cancer by looking at data from extremely small pieces of tissue—some as ...

Immunotherapy is a modern approach to cancer treatment that uses a patient’s own immune system to help fight tumors. It has ...

Though cancer doesn’t always return, understanding the factors that contribute to recurrence and being aware of available ...

In November 2024, the JP Conte Family Foundation made a transformative $5 million gift to UCSF to establish two professorships in the Department of Neurology. These endowed positions, overseen by ...

Niktimvo (axatilimab-csfr) is a first-in-class colony stimulating factor-1 receptor (CSF-1R)-blocking antibody approved for use in the U.S. for the treatment of chronic graft-versus-host disease (GVHD ...

Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research ...

Researchers discover novel targets for bladder cancer therapeutics and demonstrate that a new combination of existing drugs, including statins, blocks tumor growth in mice.